Baylor College of Medicine · BiologyMonsivais Pharmacology Lab
Diana Monsivais · Houston, Texas
Research Focus
Dr. Diana Monsivais's lab focuses on developing new treatments for endometriosis, a painful condition affecting many women. Their innovative approach seeks to find non-hormonal therapies that can effectively target the disease mechanisms without impacting hormone levels. The lab combines expertise from various fields, including biochemistry and immunology, to create new medications that can help manage this condition more effectively.
endometriosisJNK inhibitorsnon-hormonal therapypain managementtrans-differentiationbiomedical engineeringdrug discoveryreproductive biologyimmunologypharmacology
Research Aims
3AIM 01Develop selective inhibitors of Jun N-terminal kinase for endometriosis treatment.
AIM 02Assess efficacy of new JNK inhibitors in mouse models of endometriosis.
AIM 03Create diagnostic tools to stratify patients for targeted therapies based on menstrual blood cytokines.
Skills the Lab Values
cell culturein vitro assaysmouse modelsdrug developmenthigh-throughput screeningtissue engineeringflow cytometrymolecular biology techniquesbiostatisticsdiagnostic assay development
Output against the department
Publications69bottom 19% of dept.835th of 1,033
this lab
most publishedleast published
Citations1.5kbottom 9% of dept.940th of 1,033
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.